- Home
- CDT vs SGD Comparison
CDT vs SGD Comparison
Compare CDT & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- SGD
- Stock Information
- Founded
- CDT 2019
- SGD 2021
- Country
- CDT United States
- SGD United States
- Employees
- CDT N/A
- SGD N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- SGD
- Sector
- CDT Health Care
- SGD
- Exchange
- CDT Nasdaq
- SGD Nasdaq
- Market Cap
- CDT 2.2M
- SGD 1.8M
- IPO Year
- CDT N/A
- SGD N/A
- Fundamental
- Price
- CDT $2.80
- SGD $0.78
- Analyst Decision
- CDT
- SGD
- Analyst Count
- CDT 0
- SGD 0
- Target Price
- CDT N/A
- SGD N/A
- AVG Volume (30 Days)
- CDT 618.7K
- SGD 105.2K
- Earning Date
- CDT 08-11-2025
- SGD 08-22-2025
- Dividend Yield
- CDT N/A
- SGD N/A
- EPS Growth
- CDT N/A
- SGD N/A
- EPS
- CDT N/A
- SGD N/A
- Revenue
- CDT N/A
- SGD $175,906.00
- Revenue This Year
- CDT N/A
- SGD N/A
- Revenue Next Year
- CDT N/A
- SGD N/A
- P/E Ratio
- CDT N/A
- SGD N/A
- Revenue Growth
- CDT N/A
- SGD 253.11
- 52 Week Low
- CDT $2.21
- SGD $0.65
- 52 Week High
- CDT $1,515.00
- SGD $9.98
- Technical
- Relative Strength Index (RSI)
- CDT 38.74
- SGD 38.51
- Support Level
- CDT $2.57
- SGD $0.80
- Resistance Level
- CDT $3.05
- SGD $0.90
- Average True Range (ATR)
- CDT 0.23
- SGD 0.09
- MACD
- CDT 0.26
- SGD -0.02
- Stochastic Oscillator
- CDT 70.24
- SGD 0.00
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.